A phase I/II trial of HER2.taNK in glioblastoma and breast cancer

Trial Profile

A phase I/II trial of HER2.taNK in glioblastoma and breast cancer

Planning
Phase of Trial: Phase I/II

Latest Information Update: 26 Apr 2016

At a glance

  • Drugs Natural killer cell therapy (Primary)
  • Indications Breast cancer; Glioblastoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Apr 2016 New trial record
    • 15 Apr 2016 According to a NantKwest media release, this trial will be part of the Cancer Moonshot 2020 initiative and is planning to be initiated in the second half of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top